`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Case IPR2017-01053
`Patent 8,268,299
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioner
`
`v.
`
`ALCON RESEARCH, LTD.,
`Patent Owner
`
`
`Case IPR2017-01053
`Patent 8,268,299
`
`
`
`
`
`
`
`
`
`ALCON RESEARCH, LTD.’S UPDATED POWER OF ATTORNEY
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 
`
`

`

`Case IPR2017-01053
`
`Patent 8,268,299
`
`Pursuant to 37 C.F.R. § 42.10(b)(a)(3), Alcon Research, Ltd, Patent Owner
`
`of US. Patent No. 8,268,299, hereby appoints the following practitioners as its
`
`attorneys to transact all business in the Patent Trial & Appeal Board of the United
`
`States Patent and Trademark Office connected with the above—identified petition
`
`for inter partes review:
`
`David M. Krinsky (Reg. No. 72,339)
`Christopher A. Suarez (Reg. No. 72,553)
`Adam L. Perlman (Admitted Pro Hac Vice)
`Christopher J. Mandernach (Admitted Pro Has Vice)
`Alexander S. Zolan (Admitted Pro Hac Vice)
`Williams & Connolly LLP
`725 Twelfth Street, NW.
`
`Washington, DC 20005
`Tel.: 202-434-5000
`
`Fax: 202-434—5029
`
`Email: dkrinsky@wc.com, csuarez@wc.com, aperlman@wc.com,
`cmandernach@wc.com, azolan@wc.com
`
`Peter Waibel (Reg. No. 43,228)
`Drew Holmes (Reg. No. 51,813)
`Novartis Pharmaceuticals Corporation
`One Health Plaza
`
`East Hanover, NJ 07936
`Tel.: 862—778-8300
`
`Email: peter.waibel@novartiscom, drew.holmes@.novartis.com
`
`The undersigned is authorized to Sign this Power of Attorney on behalf of Alcon
`Research, Ltd.
`
`Date: November 15, 2017
`'l\.,__
`'.‘_
`~..--._
`\.
`IH‘:
`\__¢
`i\_ 1“
`1'.:1—':}_'1I\S.:.--
`.
`.
`Annette Cromer, Authorized Signatory
`
`c
`
`.
`
`‘
`
`.
`
`.
`
`'1.‘ {1 r,-m
`’
`_L'
`..
`.m.
`Maria Stachur
`
`r:-
`
`’i-L
`inf-8..
`a, Authorized Signatory
`
`

`

`
`
`
`
`
`
`
`Case IPR2017-01053
`Patent 8,268,299
`
`CERTIFICATE OF SERVICE (37 C.F.R. § 42.6(e))
`
`The undersigned hereby certifies that the foregoing “ALCON RESEARCH,
`
`LTD.’S UPDATED POWER OF ATTORNEY” was served on November 15,
`
`2017, via electronic mail upon the following attorneys of record for the Petitioner:
`
`Michael R. Houston
`Joseph P. Meara
`James P. McParland
`FOLEY & LARDNER LLP
`mhouston@foley.com
`jmeara-pgp@foley.com
`jmcparland@foley.com
`ARG-travatanZ@foley.com
`
`Tyler C. Liu
`ARGENTUM PHARMACEUTICALS LLC
`tliu@agpharm.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/David M. Krinsky/
`David M. Krinsky
`Reg. No. 72,339
`Lead Counsel for Patent Owner
`
`
`
`
`
`Dated: November 15, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 
`
`2
`
` 
`
`

`

`rt New at is
`
`Power of Attorney
`
`By this Power of Attorney, effective 01 _.lan.uery 201.7, Alco‘n Research, Ltd, a company
`incorpm'ated under the laws of the State of Delaware and having. its principal place of
`business at 6201- South Freeway, Fort Worth, TX 76134—2099 (“the Company”), hereby
`grants to the Novartis Group Companies listed below (“the Corporate- Signatorie§’):
`
`a)
`
`.b)
`
`c)
`
`the revocable authority to sign documents on behalf of the Company in
`connection with filing, prosecution, maintenance, and administration of any
`intellectual property right
`for
`copyright,
`design,_ domain
`name; patent,
`Supplementary protection certificate (SPC) and trademark registration or any
`application therefore. standing in the name of the Company (“1P”);
`
`the revocable authority to sign. documents on behalf of the Company in
`connection with litigation relating to defense of 1? before a governmental
`authority; and
`
`the revocable anther-fly to sign Cmtfirmatory Assignments on behalf of the
`Company.
`“-Confinnatory Assignments” are agreements between the Company
`and a third party or a Novartis Group entity that do not create new rights or
`obligations for the Company, such rights having been created by an underlying
`agreement (eg. ocquisiti(Jo/divestment agreement; research funding/coilaboration
`agreement, and the like) and whereby the Contirrnatory Assignment merely
`executes the transfer of II’ as agreed in such underlying agreement;
`
`and for no other purposes,
`
`This Power of Attorney excludes the power to cenclude contracts, other than
`Con‘firmatory Assignments, or to enter into settlements on behalf of the Company.
`The
`terms
`“contracts"
`and
`“settlements”
`include
`license
`agreements,
`acqu-isition/diVestment agreements, assignments, prior right agreements and/or letters of
`consent.
`
`This Power of Attorney incindes the power to appoint external agents within the scope of '
`this Power of Attorney.
`
`To be. legally binding upon the Company, all relevant documents require the signature of
`two employees of one or more of the Corporate Signatories as set out below (“Personal
`Signatories") who are authorized to sign for their respective CorpOr-ate Signatory, except
`where a single Personal Signatory is: permitted according to the. Novart-is internal
`“intellectual Property Signature Guidelines”.
`
`

`

`Corporate .Signato-r'ies-
`
`l’ersonal Signatorics
`
`Alcon Research, Ltd.
`
`Barbara McKenzie
`
`'C andy- Sanders;
`Christianne K. Garrow
`
`Christine Bohmann
`'Darien L. Reddick
`
`Deborah Weinschenk
`Denise C. Vivar
`
`Glenda Woife
`Janis M. Mondolia
`Jason Finch
`
`Jinn Zhou
`
`Joseph R. Weatherbee
`Keik-o Ichiye
`Kelly Bryant
`Kenneth D. Bassinger
`Lea Ann Rooter
`
`Martha J. Martin
`Michael Rein
`
`Patrick M. Ryan
`Robert Ambrose
`
`Roxamm Hedger
`Russell E. Henrichs
`
`Matthew A. Hayenga
`Shelley Rose~30hn_son
`Sheng-Hsin H‘u
`Stephanie-J. Boyle:
`Steven Brannon 'Latimer
`Tamika Adams
`Vanessa Backman
`
`Yolanda 1. Sanchez
`
`Alcon S. A.
`
`John Ward
`
`Page 2 01‘3
`
`

`

`Carpet-ate Signator’ies
`
`Personal Signatories
`
`NOVfll‘tiS Pharmaceuticals Corporation
`
`Andrea Jacquin
`._Annelte Cromef
`
`Cindy Klepacky
`Diane Leone
`
`Jason I. Derry
`Keliy Stri‘tenberger
`Lauren. Boseo
`Linda Adams
`Maria Stachura
`
`Mark E. Flanigan
`Scott A. Chapp'le
`Sherri Rose
`Svefl'ana 'KOI‘ZhiH
`
`This Power-of—Attomey 'is valid until 31 st December 201?? and supersedes as of its
`effective date all previous versions of Powers of Attorney relating to the subject matter
`herein.
`
`Fort Worth, 17 January 20}?
`.ALCON RESEARCI‘I, LTD.
`
`Christine Bah-mam”;
`
`Head Legal I]? and .AssiSIant Secretary
`
`Page 3 of 3
`
`